Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
By H. Sackeim, R. Haskett, Benoit H. Mulsant, M. Thase, J. Mann, H. Pettinati, Robert M. Greenberg, Raymond R. Crowe, Thomas B. Cooper, J. Prudic. Journal of the American Medical Association (JAMA), 2001
670 citations recorded by the source corpus.
Subfields: Pharmacology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/cf06eb2b17c79166af3613ddd397f92b359bea06
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
In Psychiatry and Mental health
Citations in the corpus
- Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression (2008, background): “Even with effective antidepressant medication or ECT treatment, the majority of these patients relapse over a relatively short period of time (5).”
- Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. (2010, neutral): “particularly in the initial month post-ECT (23,24).”
- Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder (2006, background): “One might consider identifying a provisional response when the response criterion is first met, then identifying a definite response when the response criterion is still met after an additional 2 weeks (Sackeim et al, 1987, 1993, 2000, 2001).”